Literature DB >> 27634761

Molecular Evolution Patterns in Metastatic Lymph Nodes Reflect the Differential Treatment Response of Advanced Primary Lung Cancer.

Sang-Won Um1, Je-Gun Joung2, Hyun Lee3, Hojoong Kim3, Kyu-Tae Kim2, Jinha Park3, D Neil Hayes4, Woong-Yang Park5,6.   

Abstract

Tumor heterogeneity influences the clinical outcome of patients with cancer, and the diagnostic method to measure the tumor heterogeneity needs to be developed. We analyzed genomic features on pairs of primary and multiple metastatic lymph nodes from six patients with lung cancer using whole-exome sequencing and RNA sequencing. Although somatic single-nucleotide variants were shared in primary lung cancer and metastases, tumor evolution predicted by the pattern of genomic alterations was matched to anatomic location of the tumors. Four of six cases exhibited a branched clonal evolution pattern. Lymph nodes with acquired somatic variants demonstrated resistance to the cancer treatment. In this study, we demonstrated that multiple biopsies and sequencing strategies for different tumor regions are required for a comprehensive understanding of the landscape of genetic alteration and for guiding targeted therapy in advanced primary lung cancer. Cancer Res; 76(22); 6568-76. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 27634761     DOI: 10.1158/0008-5472.CAN-16-0873

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Intratumoral heterogeneity and biomarkers for transformation into small cell lung carcinomas from lung adenocarcinomas.

Authors:  Hyun Lee; Sang-Won Um
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

2.  Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases.

Authors:  Zheng Hu; Zan Li; Zhicheng Ma; Christina Curtis
Journal:  Nat Genet       Date:  2020-05-18       Impact factor: 38.330

3.  Power and pitfalls of computational methods for inferring clone phylogenies and mutation orders from bulk sequencing data.

Authors:  Sayaka Miura; Tracy Vu; Jiamin Deng; Tiffany Buturla; Olumide Oladeinde; Jiyeong Choi; Sudhir Kumar
Journal:  Sci Rep       Date:  2020-02-26       Impact factor: 4.379

4.  Genomic Evolution of Lung Cancer Metastasis: Current Status and Perspectives.

Authors:  Wen-Fang Tang; Rui Fu; Yi Liang; Jie-Shan Lin; Zhen-Bin Qiu; Yi-Long Wu; Wen-Zhao Zhong
Journal:  Cancer Commun (Lond)       Date:  2021-11-29

5.  Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes.

Authors:  Alessandro Di Federico; Andrea De Giglio; Francesco Gelsomino; Dario De Biase; Francesca Giunchi; Arianna Palladini; Francesca Sperandi; Barbara Melotti; Andrea Ardizzoni
Journal:  Cancers (Basel)       Date:  2022-07-17       Impact factor: 6.575

6.  Patient-derived xenografts undergo mouse-specific tumor evolution.

Authors:  Uri Ben-David; Gavin Ha; Yuen-Yi Tseng; Noah F Greenwald; Coyin Oh; Juliann Shih; James M McFarland; Bang Wong; Jesse S Boehm; Rameen Beroukhim; Todd R Golub
Journal:  Nat Genet       Date:  2017-10-09       Impact factor: 38.330

7.  Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer.

Authors:  Tracy L Leong; Velimir Gayevskiy; Daniel P Steinfort; Marc R De Massy; Alvaro Gonzalez-Rajal; Kieren D Marini; Emily Stone; Venessa Chin; Adrian Havryk; Marshall Plit; Louis B Irving; Barton R Jennings; Rachael A McCloy; W Samantha N Jayasekara; Muhammad Alamgeer; Vishal Boolell; Andrew Field; Prudence A Russell; Beena Kumar; Daniel J Gough; Anette Szczepny; Vinod Ganju; Fernando J Rossello; Jason E Cain; Anthony T Papenfuss; Marie-Liesse Asselin-Labat; Mark J Cowley; D Neil Watkins
Journal:  Oncogene       Date:  2018-10-22       Impact factor: 9.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.